ICMR-National Institute of Cholera and Enteric diseases, Beleghata, Kolkata, West Bengal, India.
Infect Immun. 2022 Jun 16;90(6):e0011922. doi: 10.1128/iai.00119-22. Epub 2022 May 19.
Antibiotic resistance of pathogenic bacteria has emerged as a major threat to public health worldwide. While stable resistance due to the acquisition of genomic mutations or plasmids carrying antibiotic resistance genes is well established, much less is known about the temporary and reversible resistance induced by antibiotic treatment, such as that due to treatment with bacterial cell wall-inhibiting antibiotics such as ampicillin. Typically, ampicillin concentration in the blood and other tissues gradually increases over time after initiation of the treatment. As a result, the bacterial population is exposed to a concentration gradient of ampicillin during the treatment of infectious diseases. This is different from drug testing, where the organism is exposed to fixed drug concentrations from the beginning until the end. To mimic the mode of antibiotic exposure of microorganisms within host tissues, we cultured the wild-type, ampicillin-sensitive Salmonella enterica serovar Typhi Ty2 strain ( Typhi Ty2) in the presence of increasing concentrations of ampicillin over a period of 14 days. This resulted in the development of a strain that displayed several features of the so-called L-form of bacteria, including the absence of the cell wall, altered shape, and lower growth rate compared with the parental form. Studies of the pathogenesis of . Typhi L-form showed efficient infection of the murine and human macrophage cell lines. More importantly, . Typhi L-form was also able to establish infection in a mouse model to the extent comparable to its parental form. These results suggested that L-form generation following the initiation of treatment with antibiotics could lead to drug escape of . Typhi and cell to cell (macrophages) spread of the bacteria, which sustain the infection. Oral infection by the L-form bacteria underscores the potential of rapid disease transmission through the fecal-oral route, highlighting the need for new approaches to decrease the reservoir of infection.
病原菌的抗生素耐药性已成为全球公共卫生的主要威胁。虽然由于基因组突变的获得或携带抗生素耐药基因的质粒的稳定耐药已经得到充分证实,但对于抗生素治疗诱导的暂时和可逆耐药性(如由于使用氨苄青霉素等细菌细胞壁抑制抗生素治疗而产生的耐药性)知之甚少。通常,在开始治疗后,氨苄青霉素在血液和其他组织中的浓度会随时间逐渐增加。因此,在治疗传染病时,细菌种群会暴露在氨苄青霉素的浓度梯度中。这与药物测试不同,在药物测试中,从一开始到结束,生物体就会暴露在固定的药物浓度下。为了模拟宿主组织内微生物对抗生素的暴露模式,我们在 14 天的时间内,用逐渐增加的氨苄青霉素浓度培养野生型、氨苄青霉素敏感的沙门氏菌血清型 Typhi Ty2 株( Typhi Ty2)。这导致了一种表现出所谓细菌 L 型的几种特征的菌株的发展,包括细胞壁缺失、形状改变和与亲本形式相比生长速度较慢。对. Typhi L 型发病机制的研究表明,它能有效地感染鼠和人巨噬细胞系。更重要的是,. Typhi L 型也能够在小鼠模型中建立感染,其程度与亲本形式相当。这些结果表明,抗生素治疗开始后 L 型的产生可能导致. Typhi 逃避药物,并使细菌在细胞间(巨噬细胞)传播,从而维持感染。L 型细菌的口服感染表明,通过粪-口途径迅速传播疾病的可能性,突出了需要采取新方法来减少感染源。